Annual Gene Therapy Symposium for
Heart, Lung, and Blood Diseases
Information for
Register Online
Past Symposia:

UC Davis


2nd Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases
Focus Topic: Fetus and Infant
November 19-21, 2003 - Sonoma, California

Student/Fellow Presentations


Thursday, November 20


Colette C. Chambers, BS, UC Davis
Overexpression of Lefty A reduces extracellular
matrix production in hepatic stellate cells
Shuo Gu, BS, UC Davis
Creation of novel lentiviral vector
with potent anti-HIV activity
Benjamin Hendrickson, BS,
Childrens Hospital Los Angeles
Development of lentiviral vectors for
expression specifically in lung epithelia
Chistoph A. Kahl, PhD,
Indiana University School of Medicine
Lentiviral vectors pseudotyped with envelope
glycoproteins from Ross River Virus: Marked
variability in transduction related to cell type
Mi-Young Lee, BS, UC Davis
Comparison of gene expression following
DNA delivery to dermis and muscle
Mingjie Li, PhD,
City of Hope Beckman Research Institute
Development of lentiviral vectors expressing PolIII promoted therapeutic RNAs for human gene therapy
Aaron C. Logan, BS,
Childrens Hospital Los Angeles
Self-inactivating lentiviral vectors produce
genomic-length transcripts competent for
encapsidation and integration
Patrick L. Sinn, PhD, University of Iowa
Pseudotyping FIV-based lentiviral vectors:
Three glycoprotieins that confer apical entry
to airway epithelia


Friday, November 21


Yuyou Duan, PhD, UC Davis
SV-40 mediated gene therapy for bi-functional
treatment of human alpha 1-antitrypsis deficiency
in an animal model

Suzan Imren, MD, Terry Fox Laboratory
Preferred intragenic integration with high-level erythroid expression of a lentiviral vector bearing an anti-sickling Β-globin transgene in NOD/SCID mouse repopulating human cord blood cells

Daniel F. Jimenez, PhD, UC Davis
Fetal progenitor cells in the maternal circulation and long-term microchimerism in rhesus macaques (Macaca mulatta)
Kiarash Khosrotehrani, MD,
Tufts-New England Medical Center
Fetal microchimeric cells are transferred into maternal circulation during all murine pregnancies and specifically home to the damaged liver

Christina A. Pacak, BS, University of Florida
rAAV-mediated gene therapy to treat limb girdle muscular dystrophy type 2D (LGMD-2D)


Ryan Rodriguez, BS, UC San Francisco
Suppression of a stably expressed transgene in human embryonic stem cells by RNA interference



Rosa H. Won, MD, UC Davis
Maternal immune response to fetal gene therapy
in rhesus monkeys (Macaca mulatta)


Not pictured:

Jacqueline Fischer-Lougheed, PhD,
USC Keck School of Medicine
Induction of chimerism using lentiviral vectors expressing
porcine alpha 1,3 galactosyltransferase

Naoki Yamamoto, MD, UC Davis
Differentiation of human embryonic stem cells
along a hepatocyte lineage